摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-amino-N-(6-oxohexyl)hexanamide

中文名称
——
中文别名
——
英文名称
6-amino-N-(6-oxohexyl)hexanamide
英文别名
——
6-amino-N-(6-oxohexyl)hexanamide化学式
CAS
——
化学式
C12H24N2O2
mdl
——
分子量
228.33
InChiKey
OJOHXUKIDJADIL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    16
  • 可旋转键数:
    11
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    72.2
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • [EN] NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF<br/>[FR] NOUVEAUX COMPOSÉS ET LEURS UTILISATIONS THÉRAPEUTIQUES
    申请人:CENTAURI THERAPEUTICS LTD
    公开号:WO2018051085A1
    公开(公告)日:2018-03-22
    The invention relates to novel compounds with the ability to link an immune response to a pathogen,to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    这项发明涉及具有将免疫应答与病原体联系起来的能力的新化合物,以及将该化合物用于由感染性病原体介导和/或引起的疾病或紊乱的用途,包含该化合物的组合物,其制备方法以及在该过程中使用的新中间体。
  • VITAMIN E-BASED NANOCARRIERS FOR DRUG DELIVERY AND METHODS OF MAKING AND USING THE SAME
    申请人:THE CORPORATION OF MERCER UNIVERSITY
    公开号:US20170037184A1
    公开(公告)日:2017-02-09
    Vitamin E-based amphiphilic copolymers are disclosed. Compositions containing vitamin E-based amphiphilic copolymers and/or nanocarriers are also disclosed. Methods of making vitamin E-based amphiphilic copolymers and/or nanocarriers and methods of using vitamin E-based amphiphilic copolymers and/or nanocarriers are also disclosed.
  • NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF
    申请人:Centauri Therapeutics Limited (GB/GB)
    公开号:US20220162262A1
    公开(公告)日:2022-05-26
    The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
  • US9181305B2
    申请人:——
    公开号:US9181305B2
    公开(公告)日:2015-11-10
查看更多